Kenya National Cancer Control Programme (NCCP) Implementation Guide - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://fhir.dha.go.ke/terminology/ValueSet/nccp-treatment-course-codes-vs | Version: 1.0.0 | ||||
| Active as of 2026-08-18 | Computable Name: TreatmentCourseCodesVS | ||||
Standard oncology chemotherapy regimen codes used in Kenya.
References
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs version 📦1.0.0
Expansion performed internally based on codesystem Kenya Treatment Course (Regimen) Code System v1.0.0 (CodeSystem)
This value set contains 23 concepts
| System | Code | Display (en) | Definition | JSON | XML |
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | AC | AC | Doxorubicin + Cyclophosphamide | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | AC-T | AC-T | Doxorubicin + Cyclophosphamide followed by Paclitaxel | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | AC-TH | AC-TH | AC-T with Trastuzumab (HER2+) | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | CMF | CMF | Cyclophosphamide + Methotrexate + 5-Fluorouracil | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | FAC | FAC | 5-Fluorouracil + Doxorubicin + Cyclophosphamide | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | FEC | FEC | 5-Fluorouracil + Epirubicin + Cyclophosphamide | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | TC | TC | Docetaxel + Cyclophosphamide | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | FOLFOX | FOLFOX | 5-Fluorouracil + Leucovorin + Oxaliplatin | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | FOLFIRI | FOLFIRI | 5-Fluorouracil + Leucovorin + Irinotecan | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | CAPOX | CAPOX/XELOX | Capecitabine + Oxaliplatin | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | BEP | BEP | Bleomycin + Etoposide + Cisplatin | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | CHOP | CHOP | Cyclophosphamide + Doxorubicin + Vincristine + Prednisone | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | R-CHOP | R-CHOP | Rituximab + CHOP | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | ABVD | ABVD | Doxorubicin + Bleomycin + Vinblastine + Dacarbazine | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | GEM-CIS | Gem-Cis | Gemcitabine + Cisplatin | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | GEM-CARBO | Gem-Carbo | Gemcitabine + Carboplatin | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | PACLITAXEL-CARBO | Paclitaxel-Carboplatin | Paclitaxel + Carboplatin | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | CISPLATIN-5FU | Cisplatin-5FU | Cisplatin + 5-Fluorouracil | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | SINGLE-CAPECITABINE | Single-agent Capecitabine | Capecitabine monotherapy | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | SINGLE-PACLITAXEL | Single-agent Paclitaxel | Paclitaxel monotherapy | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | SINGLE-GEMCITABINE | Single-agent Gemcitabine | Gemcitabine monotherapy | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | MVAC | MVAC | Methotrexate + Vinblastine + Doxorubicin + Cisplatin | ||
https://fhir.dha.go.ke/terminology/CodeSystem/treatment-course-codes-cs | OTHER | Other | Regimen not listed; specify in free text. |